CRP flare‐response should, in the absence of other clinical symptoms, thus not be misinterpreted as a bacterial infection or another side effect after IO therapy initiation especially since antibiotic‐induced dysbiosis can compromise the clinical activity of immunotherapy by modulating, for example the gut microbiome.18 This evidence concerns the gene CRP and bacterial infectious disease.